# Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects

> **NCT02446002** · PHASE1 · COMPLETED · sponsor: **USWM, LLC (dba US WorldMeds)** · enrollment: 25 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lofexidine + Naltrexone

## Key facts

- **NCT ID:** NCT02446002
- **Lead sponsor:** USWM, LLC (dba US WorldMeds)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02446002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02446002, "Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02446002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*